328 related articles for article (PubMed ID: 10561138)
1. Leptin in peritoneal dialysate from continuous ambulatory peritoneal dialysis patients.
Tsujimoto Y; Shoji T; Tabata T; Morita A; Emoto M; Nishizawa Y; Morii H
Am J Kidney Dis; 1999 Nov; 34(5):832-8. PubMed ID: 10561138
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal clearance of leptin in continuous ambulatory peritoneal dialysis.
Arkouche W; Juillard L; Delawari E; Lasne Y; Combarnous F; Sibaï-Galland R; Traeger J; Laville M; Fouque D
Am J Kidney Dis; 1999 Nov; 34(5):839-44. PubMed ID: 10561139
[TBL] [Abstract][Full Text] [Related]
3. Amino-acid-based dialysis solution changes leptinemia and leptin peritoneal clearance.
Grzegorzewska AE; Wiecek A; Mariak I; Kokot F
Adv Perit Dial; 2000; 16():7-14. PubMed ID: 11045252
[TBL] [Abstract][Full Text] [Related]
4. Plasma leptin level and its relationship with body composition in hemodialysis patients.
Nishizawa Y; Shoji T; Tanaka S; Yamashita M; Morita A; Emoto M; Tabata T; Inoue T; Morii H
Am J Kidney Dis; 1998 Apr; 31(4):655-61. PubMed ID: 9531182
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal transport characteristics and dwelling time significantly impact ghrelin clearance in peritoneal dialysis patients.
Chang CC; Hung CH; Chen HL; Hwang KL; Lin CY
Nephrol Dial Transplant; 2007 Jan; 22(1):224-8. PubMed ID: 17005528
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
[TBL] [Abstract][Full Text] [Related]
7. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
[TBL] [Abstract][Full Text] [Related]
8. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
[TBL] [Abstract][Full Text] [Related]
9. Outcome for continuous ambulatory peritoneal dialysis patients is not predicted by peritoneal permeability characteristics.
Passadakis PS; Thodis ED; Panagoutsos SA; Selisiou CA; Pitta EM; Vargemezis VA
Adv Perit Dial; 2000; 16():2-6. PubMed ID: 11045251
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
11. [Hyperhomocysteinemia in CAPD patients: peritoneal transport of total homocysteine at peritoneal equilibration test and daily elimination of total homocysteine].
Hirose S; Kono R; Mitarai T; Isoda K; Kim S; Shimoyama H
Nihon Jinzo Gakkai Shi; 1999 Dec; 41(8):778-86. PubMed ID: 10655726
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of body size indices, residual renal function, and peritoneal transport characteristics in continuous ambulatory peritoneal dialysis.
Twardowski ZJ; Moore HL; Prowant BF; Satalowich R
Adv Perit Dial; 2009; 25():155-64. PubMed ID: 19886338
[TBL] [Abstract][Full Text] [Related]
13. Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Joffe P; Olsen F; Heaf JG; Gammelgaard B; Pödenphant J
Clin Nephrol; 1989 Sep; 32(3):133-8. PubMed ID: 2791364
[TBL] [Abstract][Full Text] [Related]
14. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
[TBL] [Abstract][Full Text] [Related]
15. Discrepancy between solute transport rate and drain volume in CAPD patients with ascites.
Yoon SN; Yang CW; Lee SH; Kim YS; Choi EJ; Chang YS; Bang BK
Adv Perit Dial; 1996; 12():39-42. PubMed ID: 8865869
[TBL] [Abstract][Full Text] [Related]
16. Interrelationship between plasma leptin concentration and severity of metabolic acidosis in haemodialysed patients with chronical renal failure.
Kokot F; Chudek J; Adamczak M; Wieçek A
Exp Clin Endocrinol Diabetes; 2001; 109(7):370-3. PubMed ID: 11573148
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal clearance of leptin in CAPD patients: impact of local insulin administration.
Heimbürger O; Wang T; Lönnqvist F; Stenvinkel P
Nephrol Dial Transplant; 1999 Mar; 14(3):723-7. PubMed ID: 10193827
[TBL] [Abstract][Full Text] [Related]
18. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
[TBL] [Abstract][Full Text] [Related]
19. Dialysis adequacy and transport test for characterization of peritoneal transport type in Chinese peritoneal dialysis patients receiving three daily exchanges.
Szeto CC; Wong TY; Chow KM; Leung CB; Li PK
Am J Kidney Dis; 2002 Jun; 39(6):1287-99. PubMed ID: 12046043
[TBL] [Abstract][Full Text] [Related]
20. Continuous ambulatory peritoneal dialysis with a high flux membrane. A preliminary report.
Nolph KD; Moore HL; Prowant B; Twardowski ZJ; Khanna R; Gamboa S; Keshaviah P
ASAIO J; 1993; 39(3):M566-8. PubMed ID: 8268600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
